Over 100 years ago Western New York gave modern cancer research to the world through what would become the Roswell Park Cancer Institute. Today our region continues to lead the way in medical and scientific research. As a Member of the House Cancer Caucus, Brian has been a steadfast supporter for cancer research, both for local researchers and for the nation’s cancer program generally. Brian has led efforts among his colleagues to increase funding for cancer research and is engaged with the cancer community on innovations that will alleviate suffering due to cancer and ultimately find a cure. Brian has introduced H.R. 1801, the Cancer Drug Coverage Parity Act, which would require health insurance companies to provide the same coverage for new, promising orally-administered anti-cancer medication as it does for traditional intravenous chemotherapy.
More on Cancer Research
The National Cancer Institute (NCI) has affirmed its support for Roswell Park Comprehensive Cancer Center, renewing its status as one of 50 elite Comprehensive Cancer Centers and awarding a $22.5 million Cancer Center Support Grant (CCSG) to fund core research and education programs — the largest such award and highest application score in Roswell Park’s history. Roswell Park has held this prestigious NCI designation continuously since it became one of the nation’s very first Comprehensive Cancer Centers more than 45 years ago.
Congressmembers Brian Higgins (D-NY-26) and Peter King (R-NY-2) are leading a bipartisan effort in Congress to provide at least $6.522 billion in overall funding for the National Cancer Institute (NCI) in Fiscal Year 2020, a $378 million increase over FY2019 levels, and $1.275 billion more than proposed in the White House 2020 budget.
ring a House Budget Committee hearing with the Department of Health and Human Services Deputy Secretary Eric Hargan, Congressman Brian Higgins (NY-26) raised serious questions about the rationale of cutting hundreds of millions of dollars in cancer research funding from the 2020 budget.
In a House of Representatives Budget Committee hearing reviewing the recently released 2020 budget proposed by President Trump, Budget Committee member Congressman Brian Higgins (NY-26) questioned the Administration’s justification for drastic cuts in medical research generally, and cancer research specifically.
Washington, DC - U.S. Senate Minority Leader Charles E. Schumer, U.S. Senator Kirsten Gillibrand, and Congressman Brian Higgins (NY-26) are supporting Roswell Park Comprehensive Cancer Center’s application to renew the facility’s esteemed standing as a National Cancer Institute (NCI) designated comprehensive cancer center, which also guarantees a federal commitment of millions of dollars.
Following release of President Trump’s Fiscal Year 2019 Budget, Congressman Brian Higgins (NY-26), a member of the House Budget Committee, is outlining how the proposal would impact the people of Western New York as well as the projects and priorities of importance to the region.
Washington D.C. – Two co-chairs of the House Cancer Caucus, Representatives Derek Kilmer (D-WA-06) and Brian Higgins (D-NY-26), pushed back against a President Trump budget proposal that includes severe cuts to scientific research into stopping the spread of cancer.
This week the House of Representatives approved H.R. 3381, the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act. The legislation, cosponsored by Congressman Brian Higgins (NY-26), had broad bipartisan support.